$LOCL
Local Bounti Corporation/DE Stock $locl

$locl Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022007907 Filed on March 30, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$314.0K	$638.0K	$43.00K
YoY Change	630.23%	678.05%
Cost Of Revenue	$183.0K	$432.0K	$83.00K
YoY Change	120.48%	374.73%
Gross Profit	$131.0K	$206.0K	-$40.00K
YoY Change	-427.5%	-2388.89%
Gross Profit Margin	41.72%	32.29%	-93.02%
Selling, General & Admin	$26.01M	$41.50M	$2.611M
YoY Change	895.98%	507.23%
% of Gross Profit	19851.15%	20144.66%
Research & Development	$1.180M	$3.425M	$721.0K
YoY Change	63.66%	217.42%
% of Gross Profit	900.76%	1662.62%
Depreciation & Amortization	$292.0K	$684.0K	$105.0K
YoY Change	178.1%	138.33%
% of Gross Profit	222.9%	332.04%
Operating Expenses	$26.79M	$44.92M	$3.150M
YoY Change	750.57%	467.71%
Operating Profit	-$26.66M	-$44.72M	-$3.190M
YoY Change	735.8%	464.47%
Interest Expense	-$1.866M	-$5.133M	-$205.0K
YoY Change	810.24%	883.33%
% of Operating Profit
Other Income/Expense, Net	$257.0K	$230.0K	$14.00K
YoY Change	1735.71%
Pretax Income	-$28.27M	-$56.09M	-$3.381M
YoY Change	736.17%	567.06%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$28.27M	-$56.09M	-$3.381M
YoY Change	736.17%	567.06%
Net Earnings / Revenue	-9003.5%	-8792.01%	-7862.79%
Basic Earnings Per Share		-$1.06
Diluted Earnings Per Share	-$327.0K	-$1.06	-$39.16K
COMMON SHARES
Basic Shares Outstanding		52.89M shares
Diluted Shares Outstanding		52.89M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$96.66M	$96.66M
YoY Change		214702.22%
Cash & Equivalents	$96.66M	$96.66M	$45.00K
Short-Term Investments
Other Short-Term Assets	$7.807M	$7.807M
YoY Change		111428.57%
Inventory	$922.0K	$922.0K	$243.0K
Prepaid Expenses
Receivables	$110.0K	$118.0K	$11.00K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$105.5M	$105.5M	$628.0K
YoY Change	16700.64%	16700.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.35M	$37.41M
YoY Change		344.08%
Goodwill	$0.00
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.017M	$1.017M	$51.00K
YoY Change	1894.12%	1894.12%
Total Long-Term Assets	$38.42M	$38.42M	$8.474M
YoY Change	353.41%	353.41%
TOTAL ASSETS
Total Short-Term Assets	$105.5M	$105.5M	$628.0K
Total Long-Term Assets	$38.42M	$38.42M	$8.474M
Total Assets	$143.9M	$143.9M	$9.102M
YoY Change	1481.3%	1481.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.920M	$1.912M	$176.0K
YoY Change	990.91%	986.36%
Accrued Expenses	$16.02M	$16.06M	$1.294M
YoY Change	1138.02%	654.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.97M	$17.97M	$2.353M
YoY Change	663.62%	663.62%
LONG-TERM LIABILITIES
Long-Term Debt	$11.20M	$24.27M	$104.0K
YoY Change	10668.27%	160.4%
Other Long-Term Liabilities	$10.00K	$10.00K	$0.00
YoY Change
Total Long-Term Liabilities	$11.21M	$24.28M	$104.0K
YoY Change	10677.88%	160.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.97M	$17.97M	$2.353M
Total Long-Term Liabilities	$11.21M	$24.28M	$104.0K
Total Liabilities	$42.25M	$42.25M	$11.67M
YoY Change	261.92%	261.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.24M		-$12.15M
YoY Change	461.71%
Common Stock	$9.000K		$1.000K
YoY Change	800.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$101.7M	$101.7M	-$2.571M
YoY Change
Total Liabilities & Shareholders Equity	$143.9M	$143.9M	$9.102M
YoY Change	1481.3%	1481.3%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$28.27M	-$56.09M	-$3.381M
YoY Change	736.17%	567.06%
Depreciation, Depletion And Amortization	$292.0K	$684.0K	$105.0K
YoY Change	178.1%	138.33%
Cash From Operating Activities	-$4.828M	-$20.11M	-$191.0K
YoY Change	2427.75%	423.92%
INVESTING ACTIVITIES
Capital Expenditures	-$15.47M	$29.67M	$301.0K
YoY Change	-5240.53%	766.92%
Acquisitions		$0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$15.47M	-$29.67M	$301.0K
YoY Change	-5240.53%	766.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	106.6M	$150.8M	-147.0K
YoY Change	-72607.48%	2818.07%
NET CHANGE
Cash From Operating Activities	-4.828M	-$20.11M	-191.0K
Cash From Investing Activities	-15.47M	-$29.67M	301.0K
Cash From Financing Activities	106.6M	$150.8M	-147.0K
Net Change In Cash	86.29M	$101.0M	-37.00K
YoY Change	-233302.7%	-4929.45%
FREE CASH FLOW
Cash From Operating Activities	-$4.828M	-$20.11M	-$191.0K
Capital Expenditures	-$15.47M	$29.67M	$301.0K
Free Cash Flow	$10.65M	-$49.77M	-$492.0K
YoY Change	-2263.62%	585.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Registrant Name EntityRegistrantName	Local Bounti Corporation/DE
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001840780
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity File Number EntityFileNumber	001-40125
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1584830
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	490 Foley Lane
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8423000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1017000	USD
CY2021	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	USD
CY2021Q4	us-gaap	Assets Assets	143930000	USD
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	MT
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59840
CY2021	dei	City Area Code CityAreaCode	406
CY2021	dei	Local Phone Number LocalPhoneNumber	361-3711
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	271400000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86465757	shares
CY2021	dei	Auditor Firm AuditorFirmId	100
CY2020Q4	us-gaap	Assets Assets	9102000	USD
CY2021	dei	Auditor Location AuditorLocation	Whippany, New Jersey
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96661000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4416000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11000	USD
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	8000	USD
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	322000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	922000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	243000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3391000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	105508000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	628000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	37405000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1912000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	176000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16048000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1294000	USD
CY2021Q4	locl	Accrued Liabilities Related Party Current AccruedLiabilitiesRelatedPartyCurrent	8000	USD
CY2020Q4	locl	Accrued Liabilities Related Party Current AccruedLiabilitiesRelatedPartyCurrent	833000	USD
CY2021Q4	locl	Share Settlement Note ShareSettlementNote	0	USD
CY2020Q4	locl	Share Settlement Note ShareSettlementNote	50000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17968000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2353000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11199000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	104000	USD
CY2021Q4	locl	Financing Obligation FinancingObligation	13070000	USD
CY2020Q4	locl	Financing Obligation FinancingObligation	9216000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	42247000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	11673000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86344881	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86344881	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58076019	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58076019	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169916000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9577000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68242000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12149000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101683000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2571000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143930000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9102000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	638000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	432000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	91000	USD
CY2021	us-gaap	Gross Profit GrossProfit	206000	USD
CY2020	us-gaap	Gross Profit GrossProfit	-9000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3425000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1079000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41498000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6834000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	44923000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	7913000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-44717000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-7922000	USD
CY2021	locl	Management Fee Income ManagementFeeIncome	79000	USD
CY2020	locl	Management Fee Income ManagementFeeIncome	35000	USD
CY2021	locl	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	5067000	USD
CY2020	locl	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	0	USD
CY2021	locl	Debt Extinguishment Expense DebtExtinguishmentExpense	1485000	USD
CY2020	locl	Debt Extinguishment Expense DebtExtinguishmentExpense	0	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5133000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-522000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	230000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56093000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8409000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-56093000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8409000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52888268	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52888268	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49676523	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49676523	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2554000	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	11000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3295000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8409000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2571000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	30422000	USD
CY2021	locl	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	137531000	USD
CY2021	locl	Adjustments To Additional Paid In Capital Cash Distribution Reverse Recapitalization Transaction AdjustmentsToAdditionalPaidInCapitalCashDistributionReverseRecapitalizationTransaction	27320000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	32241000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17895000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-56093000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101683000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-56093000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8409000	USD
CY2021	us-gaap	Depreciation Depreciation	684000	USD
CY2020	us-gaap	Depreciation Depreciation	287000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17895000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3295000	USD
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	19000	USD
CY2020	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	-26000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021	locl	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	5067000	USD
CY2020	locl	Fair Value Adjustment Of Convertible Notes FairValueAdjustmentOfConvertibleNotes	0	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021	locl	Gain Loss On Convertible Notes GainLossOnConvertibleNotes	240000	USD
CY2020	locl	Gain Loss On Convertible Notes GainLossOnConvertibleNotes	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-939000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	782000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	1364000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	120000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-313000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	322000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3838000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29666000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	652000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	243000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3384000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	966000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	51000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1737000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	29000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	10000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2021	locl	Increase Decrease In Warrant Liabilities IncreaseDecreaseInWarrantLiabilities	-1425000	USD
CY2020	locl	Increase Decrease In Warrant Liabilities IncreaseDecreaseInWarrantLiabilities	0	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14795000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1095000	USD
CY2021	locl	Increase Decrease In Accrued Liabilities Related Party IncreaseDecreaseInAccruedLiabilitiesRelatedParty	-817000	USD
CY2020	locl	Increase Decrease In Accrued Liabilities Related Party IncreaseDecreaseInAccruedLiabilitiesRelatedParty	491000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20108000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3422000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29666000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3422000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	30422000	USD
CY2021	locl	Proceeds From Recapitalization Net Of Issuance Costs ProceedsFromRecapitalizationNetOfIssuanceCosts	137532000	USD
CY2020	locl	Proceeds From Recapitalization Net Of Issuance Costs ProceedsFromRecapitalizationNetOfIssuanceCosts	0	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	26000000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2021	locl	Proceeds From Financing Obligations ProceedsFromFinancingObligations	3854000	USD
CY2020	locl	Proceeds From Financing Obligations ProceedsFromFinancingObligations	7675000	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	26793000	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	453000	USD
CY2021	locl	Cash Distribution Recapitalization Transaction CashDistributionRecapitalizationTransaction	27320000	USD
CY2020	locl	Cash Distribution Recapitalization Transaction CashDistributionRecapitalizationTransaction	0	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5399000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	10654000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	2880000	USD
CY2021	locl	Payments Of Share Settlement PaymentsOfShareSettlement	0	USD
CY2020	locl	Payments Of Share Settlement PaymentsOfShareSettlement	80000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150806000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5168000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	101032000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2092000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2137000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101077000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2981000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	49000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12441000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1541000	USD
CY2021	locl	Noncash Redemption Of Common Stock NoncashRedemptionOfCommonStock	0	USD
CY2020	locl	Noncash Redemption Of Common Stock NoncashRedemptionOfCommonStock	11000	USD
CY2021	locl	Noncash Proceeds From Issuance Of Convertible Notes NoncashProceedsFromIssuanceOfConvertibleNotes	50000	USD
CY2020	locl	Noncash Proceeds From Issuance Of Convertible Notes NoncashProceedsFromIssuanceOfConvertibleNotes	0	USD
CY2021	locl	Noncash Proceeds From Issuance Of Share NoncashProceedsFromIssuanceOfShare	0	USD
CY2020	locl	Noncash Proceeds From Issuance Of Share NoncashProceedsFromIssuanceOfShare	80000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96661000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4416000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101077000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="padding-right:0.55pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reclassification</span></div><div style="padding-right:0.55pt;text-align:justify"><span><br/></span></div><div style="padding-right:0.55pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company reclassified depreciation in the Consolidated Statements of Operations for the year ended December 31, 2020 to conform to the presentation for the year ended December 31, 2021. Depreciation is no longer stated as a separate financial statement line item on the Consolidated Statements of Operations but it has instead been allocated to cost of goods sold, research and development, and selling, general and administrative expense on the Consolidated Statements of Operations for the years ended December 31, 2021 and 2020. This reclassification had no impact on loss from operations or net loss. The Company believes this reclassification is preferable because it enhances the comparability of its Consolidated Financial Statements with those of many of its industry peers and aligns with how the Company internally manages and reviews costs and margin.</span></div>
CY2021Q4	locl	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	4.969669
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The preparation of the Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of instruments issued for stock-based compensation, inventory valuation reserve, warrant liabilities, and income taxes, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making </span></div>judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4416000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	638000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	703000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	0	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Concentrations of Risk and Significant Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents accounts with financial institutions which management believes to be of high-credit quality. The Company is exposed to risk in the event of default by these financial institutions or the issuers of these securities to the extent the balances are in excess of amounts that are insured by the Federal Deposit Insurance Corporation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company’s receivables are derived from revenue earned from customers located in the United States. The Company provides credit to its customers in the normal course of business and requires no collateral to secure accounts receivable. The Company maintains an allowance for doubtful accounts related to estimated credit losses.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant customers are those customers who represent 10% or more of total revenue during the year or 10% or more of net accounts receivable at the balance sheet date. At December 31, 2021, there were four significant customers that accounted for approximately 81% of the Company's accounts receivable. For the year ended December 31, 2021, four individual customers represented more than 10% of total revenue. In aggregate, these four customers represented approximately 82% of the Company's revenue for the year ended December 31, 2021.</span></div>
CY2021Q4	locl	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	4.969669
CY2021Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	15000000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	150000000	USD
CY2021Q4	locl	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	150000000	USD
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	83514977	shares
CY2021Q4	locl	Transaction Costs Incurred Reverse Recapitalization Transaction TransactionCostsIncurredReverseRecapitalizationTransaction	34773000	USD
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	30422000	USD
CY2021Q4	locl	Professional Fees Reverse Recapitalization Transaction ProfessionalFeesReverseRecapitalizationTransaction	4351000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	145000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	21000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	173000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	83000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	69000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5000	USD
CY2021Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	467000	USD
CY2020Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	182000	USD
CY2021Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	163000	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	21000	USD
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	95000	USD
CY2020Q4	us-gaap	Inventory Adjustments InventoryAdjustments	69000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	922000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	243000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	55000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	971000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	287000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	37405000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8423000	USD
CY2021	us-gaap	Depreciation Depreciation	684000	USD
CY2020	us-gaap	Depreciation Depreciation	287000	USD
CY2021Q4	locl	Accrued Construction Expenses Current AccruedConstructionExpensesCurrent	11192000	USD
CY2020Q4	locl	Accrued Construction Expenses Current AccruedConstructionExpensesCurrent	0	USD
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2582000	USD
CY2020Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	792000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1125000	USD
CY2021Q4	locl	Accrued Agriculture Expenses Current AccruedAgricultureExpensesCurrent	461000	USD
CY2020Q4	locl	Accrued Agriculture Expenses Current AccruedAgricultureExpensesCurrent	0	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	273000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	748000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	169000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16048000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1294000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	11199000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	154000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11199000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	104000	USD
CY2020Q2	locl	Sale And Finance Leaseback Transaction Consideration SaleAndFinanceLeasebackTransactionConsideration	6885000	USD
CY2020Q2	locl	Sale And Finance Leaseback Transaction Initial Term SaleAndFinanceLeasebackTransactionInitialTerm	P15Y
CY2020Q2	locl	Sale And Finance Leaseback Transaction Number Of Extensions SaleAndFinanceLeasebackTransactionNumberOfExtensions	3	term
CY2020Q2	locl	Sale And Finance Leaseback Transaction Extension Period SaleAndFinanceLeasebackTransactionExtensionPeriod	P5Y
CY2020Q2	locl	Management Services Agreement Annual Fee ManagementServicesAgreementAnnualFee	50000	USD
CY2020Q2	locl	Management Services Agreement Initial Term ManagementServicesAgreementInitialTerm	P3Y
CY2020Q2	locl	Management Services Agreement Autorenewal Period ManagementServicesAgreementAutorenewalPeriod	P1Y
CY2020Q2	locl	Management Services Agreement Termination Notice Period ManagementServicesAgreementTerminationNoticePeriod	P30D
CY2020Q2	locl	Sale And Finance Leaseback Transaction Imputed Interest Rate SaleAndFinanceLeasebackTransactionImputedInterestRate	0.1160
CY2021	locl	Amortization Of Financing Obligation Assets AmortizationOfFinancingObligationAssets	433000	USD
CY2020	locl	Amortization Of Financing Obligation Assets AmortizationOfFinancingObligationAssets	215000	USD
CY2021	locl	Finance Obligation Interest FinanceObligationInterest	1076000	USD
CY2020	locl	Finance Obligation Interest FinanceObligationInterest	475000	USD
CY2021	locl	Financing Obligation Assets Amortization And Interest On Financing Obligation FinancingObligationAssetsAmortizationAndInterestOnFinancingObligation	1509000	USD
CY2020	locl	Financing Obligation Assets Amortization And Interest On Financing Obligation FinancingObligationAssetsAmortizationAndInterestOnFinancingObligation	690000	USD
CY2021Q4	locl	Financing Obligation To Be Paid Year One FinancingObligationToBePaidYearOne	1479000	USD
CY2021Q4	locl	Financing Obligation To Be Paid Year Two FinancingObligationToBePaidYearTwo	1537000	USD
CY2021Q4	locl	Financing Obligation To Be Paid Year Three FinancingObligationToBePaidYearThree	1591000	USD
CY2021Q4	locl	Financing Obligation To Be Paid Year Four FinancingObligationToBePaidYearFour	1623000	USD
CY2021Q4	locl	Financing Obligation To Be Paid Year Five FinancingObligationToBePaidYearFive	1655000	USD
CY2021Q4	locl	Financing Obligation To Be Paid After Year Five FinancingObligationToBePaidAfterYearFive	26597000	USD
CY2021Q4	locl	Financing Obligation Payments Due FinancingObligationPaymentsDue	34482000	USD
CY2021Q4	locl	Financing Obligation Interest FinancingObligationInterest	25294000	USD
CY2021Q4	locl	Financing Obligation And Asset Net FinancingObligationAndAssetNet	3882000	USD
CY2021Q4	locl	Financing Obligation FinancingObligation	13070000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	377000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	37000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	139000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	96000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	90000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	325000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86299495	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11539216	shares
CY2021Q4	locl	Common Stock Vote Per Share CommonStockVotePerShare	1	vote
CY2021Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	15000000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86299495	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	15000000	shares
CY2021Q4	locl	Stock Issued During Period Shares New Issues Percentage StockIssuedDuringPeriodSharesNewIssuesPercentage	0.174
CY2021Q4	locl	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	62482214	shares
CY2021Q4	locl	Stock Issued During Period Shares Reverse Recapitalization Percentage StockIssuedDuringPeriodSharesReverseRecapitalizationPercentage	0.723
CY2021Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	241000	shares
CY2021Q4	locl	Stock Issued During Period Shares Issued For Services Percentage StockIssuedDuringPeriodSharesIssuedForServicesPercentage	0.003
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86299495	shares
CY2021Q4	locl	Common Stock Shares Outstanding Percentage CommonStockSharesOutstandingPercentage	1.000
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10833333	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	locl	Class Of Warrant Or Right Exercise Term Period After Closing ClassOfWarrantOrRightExerciseTermPeriodAfterClosing	P30D
CY2021Q4	locl	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q4	locl	Class Of Warrant Or Right Prior Written Notice Of Redemption Period ClassOfWarrantOrRightPriorWrittenNoticeOfRedemptionPeriod	P30D
CY2021Q4	us-gaap	Share Price SharePrice	18.00
CY2021Q4	locl	Class Of Warrant Or Right Redemption Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays	20	day
CY2021Q4	locl	Class Of Warrant Or Right Redemption Threshold Trading Period ClassOfWarrantOrRightRedemptionThresholdTradingPeriod	30	day
CY2021Q4	locl	Class Of Warrant Or Right Redemption Period Before Redemption Notice Sent ClassOfWarrantOrRightRedemptionPeriodBeforeRedemptionNoticeSent	3	day
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10833333	shares
CY2021	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	705883	shares
CY2019	locl	Settlement To Repurchase Restricted Shares Amount SettlementToRepurchaseRestrictedSharesAmount	149000	USD
CY2020Q2	locl	Settlement To Repurchase Restricted Shares Amount SettlementToRepurchaseRestrictedSharesAmount	80000	USD
CY2021Q4	locl	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	4.969669
CY2021Q4	locl	Share Based Compensation Arrangement By Share Based Payment Award Awards Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsOutstandingNumber	12630417	shares
CY2021Q4	locl	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	4.969669
CY2021Q4	locl	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	4.969669
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	41800000	USD
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	7200000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6129000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1841000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2163000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	591000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8292000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2432000	USD
CY2021	locl	Deferred Income Tax Expense Benefit Valuation Allowance DeferredIncomeTaxExpenseBenefitValuationAllowance	8292000	USD
CY2020	locl	Deferred Income Tax Expense Benefit Valuation Allowance DeferredIncomeTaxExpenseBenefitValuationAllowance	2432000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11619000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1990000	USD
CY2021Q4	locl	Deferred Tax Assets Right Of Use Asset And Liability DeferredTaxAssetsRightOfUseAssetAndLiability	3661000	USD
CY2020Q4	locl	Deferred Tax Assets Right Of Use Asset And Liability DeferredTaxAssetsRightOfUseAssetAndLiability	979000	USD
CY2021Q4	locl	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	1207000	USD
CY2020Q4	locl	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16487000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2969000	USD
CY2021Q4	locl	Deferred Tax Liabilities Franchise Tax DeferredTaxLiabilitiesFranchiseTax	598000	USD
CY2020Q4	locl	Deferred Tax Liabilities Franchise Tax DeferredTaxLiabilitiesFranchiseTax	0	USD
CY2021Q4	locl	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	3071000	USD
CY2020Q4	locl	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1714000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	156000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5383000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	156000	USD
CY2021Q4	locl	Net Deferred Tax Assets Before Valuation Allowance NetDeferredTaxAssetsBeforeValuationAllowance	11104000	USD
CY2020Q4	locl	Net Deferred Tax Assets Before Valuation Allowance NetDeferredTaxAssetsBeforeValuationAllowance	2813000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11104000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2813000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	8291000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2432000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56093000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8409000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52888268	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52888268	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49676523	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49676523	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021Q4	locl	Non Cancelable Purchase Commitments Amount NonCancelablePurchaseCommitmentsAmount	1004000	USD
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	180000	USD
CY2021Q4	locl	Debt Instrument Covenant Minimum Liquidity Amount DebtInstrumentCovenantMinimumLiquidityAmount	30000000	USD

Files In Submission

Name	View Source	Status
0001628280-22-007907-index-headers.html	Edgar Link	pending
0001628280-22-007907-index.html	Edgar Link	pending
0001628280-22-007907.txt	Edgar Link	pending
0001628280-22-007907-xbrl.zip	Edgar Link	pending
exhibit10112020equityincen.htm	Edgar Link	pending
exhibit231-withumconsent.htm	Edgar Link	pending
exhibit232-rsmlocalbountic.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit32-certificateofame.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
exhibit44-descriptionofsec.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_10.jpg	Edgar Link	pending
image_13a.jpg	Edgar Link	pending
image_14.jpg	Edgar Link	pending
image_15.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_20.jpg	Edgar Link	pending
image_24a.jpg	Edgar Link	pending
image_28.jpg	Edgar Link	pending
image_29a.jpg	Edgar Link	pending
image_2a.jpg	Edgar Link	pending
image_30a.jpg	Edgar Link	pending
image_35a.jpg	Edgar Link	pending
image_36a.jpg	Edgar Link	pending
image_37a.jpg	Edgar Link	pending
image_38a.jpg	Edgar Link	pending
image_39a.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_40.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
image_9.jpg	Edgar Link	pending
locl-20211231.htm	Edgar Link	pending
locl-20211231.xsd	Edgar Link	pending
locl-20211231_cal.xml	Edgar Link	unprocessable
locl-20211231_def.xml	Edgar Link	unprocessable
locl-20211231_g1.gif	Edgar Link	pending
locl-20211231_g10.jpg	Edgar Link	pending
locl-20211231_g2.jpg	Edgar Link	pending
locl-20211231_g3.jpg	Edgar Link	pending
locl-20211231_g4.jpg	Edgar Link	pending
locl-20211231_g5.jpg	Edgar Link	pending
locl-20211231_g6.jpg	Edgar Link	pending
locl-20211231_g7.jpg	Edgar Link	pending
locl-20211231_g8.jpg	Edgar Link	pending
locl-20211231_g9.jpg	Edgar Link	pending
locl-20211231_htm.xml	Edgar Link	completed
locl-20211231_lab.xml	Edgar Link	unprocessable
locl-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOCL
Local Bounti Corporation/DE Stock $locl

2021 Q4 Form 10-K Financial Statement

#000162828022007907 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOCL Local Bounti Corporation/DE Stock $locl

2021 Q4 Form 10-K Financial Statement

#000162828022007907 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOCL
Local Bounti Corporation/DE Stock $locl